A SHP-2 inhibitor
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

RMC-4630

Item No. 38772

Technical Information
Formal Name
6-[(2-amino-3-chloro-4-pyridinyl)thio]-3-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]dec-8-yl]-5-methyl-2-pyrazinemethanol
CAS Number
2172652-48-9
Synonyms
  • SAR442720
Molecular Formula
C20H27ClN6O2S
Formula Weight
Purity
≥98%
Formulation
A solid
Acetonitrile: Slightly SolubleDMSO: SolubleWater: Slightly Soluble
SMILES
N[C@H]1C2(CO[C@H]1C)CCN(C3=NC(C)=C(N=C3CO)SC4=CC=NC(N)=C4Cl)CC2
InChi Code
InChI=1S/C20H27ClN6O2S/c1-11-19(30-14-3-6-24-17(23)15(14)21)26-13(9-28)18(25-11)27-7-4-20(5-8-27)10-29-12(2)16(20)22/h3,6,12,16,28H,4-5,7-10,22H2,1-2H3,(H2,23,24)/t12-,16+/m0/s1
InChi Key
HISJAYUQVHMWTA-BLLLJJGKSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    RMC-4630 is an allosteric inhibitor of Src homology region 2 domain-containing phosphatase 2 (SHP-2).1,2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Jogalekar, A., Won, W., Koltun, E.S., et al2,5-Disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors. WO2018013597A1, (2018).

    2. Smith, J.A., Singh, M., Nichols, R.J., et alAbstract 1943: SHP2 inhibition as the backbone of targeted therapy combinations for the treatment of cancers driven by oncogenic mutations in the RAS pathway. Cancer Res. 80(16 Suppl), 1943 (2020).